Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 11.70 is 52% below its 5-year average of 24.17, near the low end of its 5-year range (11.70–52.06).
As of the fiscal period ended Tuesday, June 30, 2026. 5.80% below its 12-month average of 12.42.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 11.70.
QUICK RATIO (ACID-TEST)
11.70
QUICK RATIO (ACID-TEST) AVG TTM
12.42
QUICK RATIO (ACID-TEST) AVG 3Y
18.68
QUICK RATIO (ACID-TEST) AVG 5Y
24.17
QUICK RATIO (ACID-TEST) AVG 10Y
13.46
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-5.80%
CURRENT VS 3Y AVG
-37.36%
CURRENT VS 5Y AVG
-51.58%
CURRENT VS 10Y AVG
-13.05%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 736 covered companies
CURRENT VS SECTOR MEDIAN
+266.84%
vs the sector median at left
enVVeno Medical Corporation
Market Cap
$5.60M
Quick Ratio (Acid-Test)
11.70
TTM Avg
12.42
3Y Avg
18.68
5Y Avg
24.17
Market Cap
$5.72M
Quick Ratio (Acid-Test)
3.88
TTM Avg
2.19
3Y Avg
2.86
5Y Avg
5.66
Market Cap
$5.77M
Quick Ratio (Acid-Test)
2.35
TTM Avg
1.31
3Y Avg
0.84
5Y Avg
0.78
Market Cap
$6.10M
Quick Ratio (Acid-Test)
2.97
TTM Avg
1.81
3Y Avg
1.20
5Y Avg
3.15
Market Cap
$5.25M
Quick Ratio (Acid-Test)
3.01
TTM Avg
3.95
3Y Avg
2.52
5Y Avg
4.28
Market Cap
$5.24M
Quick Ratio (Acid-Test)
1.35
TTM Avg
1.00
3Y Avg
0.98
5Y Avg
1.86
Market Cap
$5.24M
Quick Ratio (Acid-Test)
4.70
TTM Avg
11.62
3Y Avg
9.03
5Y Avg
8.72
Market Cap
$5.23M
Quick Ratio (Acid-Test)
0.09
TTM Avg
0.18
3Y Avg
0.40
5Y Avg
0.95
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| enVVeno Medical Corporation (NVNO) | $5.60M | 11.70 | 12.42 | 18.68 | 24.17 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.72M | 3.88 | 2.19 | 2.86 | 5.66 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.77M | 2.35 | 1.31 | 0.84 | 0.78 |
| Lucyd, Inc (LUCY)vs › | $5.85M | 11.25 | 9.38 | 8.32 | 5.66 |
| Scienture Holdings, Inc. (SCNX)vs › | $6.10M | 2.97 | 1.81 | 1.20 | 3.15 |
| Alzamend Neuro Inc (ALZN)vs › | $5.25M | 3.01 | 3.95 | 2.52 | 4.28 |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | 1.35 | 1.00 | 0.98 | 1.86 |
| Pulmatrix, Inc. (PULM)vs › | $5.24M | 4.70 | 11.62 | 9.03 | 8.72 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.23M | 0.09 | 0.18 | 0.40 | 0.95 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.98M | 119.39 | 100.04 | 53.35 | 40.07 |
Quick Ratio
11.70
Excludes inventory
Current Ratio
11.70
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 11.70 |
| 2026-03-31 | 11.89 |
| 2025-12-31 | 13.58 |
| 2025-09-30 | 13.12 |
| 2025-06-30 | 11.81 |
| 2025-03-31 | 23.77 |
| 2024-12-31 | 20.88 |
| 2024-09-30 | 22.01 |
| 2024-06-30 | 23.33 |
| 2024-03-31 | 29.08 |
| 2023-12-31 | 34.23 |
| 2023-09-30 | 12.91 |
| 2023-06-30 | 14.57 |
| 2023-03-31 | 29.58 |
| 2022-12-31 | 25.78 |
| 2022-09-30 | 31.22 |
| 2022-06-30 | 20.79 |
| 2022-03-31 | 40.67 |
| 2021-12-31 | 34.83 |
| 2021-09-30 | 52.06 |
| 2021-06-30 | 29.74 |
| 2021-03-31 | 23.57 |
| 2020-12-31 | 3.00 |
| 2020-09-30 | 3.12 |
| 2020-06-30 | 0.60 |
| 2020-03-31 | 0.37 |
| 2019-12-31 | 0.76 |
| 2019-09-30 | 1.52 |
| 2019-06-30 | 2.46 |
| 2019-03-31 | 1.60 |
| 2018-12-31 | 1.86 |
| 2018-09-30 | 2.30 |
| 2018-06-30 | 2.35 |
| 2018-03-31 | 0.03 |
| 2017-12-31 | 0.02 |
| 2017-09-30 | 0.10 |
| 2017-06-30 | 0.11 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 0.15 |
| 2016-09-30 | 0.31 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.38 |
